Back to results
US 2005/0032812 A1Published application
Compounds for the reduction of excessive food intake
AssigneeBoehringer Ingelheim Pharma GmbH & Co. KG
InventorsMichael Pieper, Joachim Mierau
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of dopamine receptor agonists for preparing a pharmaceutical composition for the reduction of excessive food intake.
Claims11
A method for treating overweight or obesity comprising administering a pharmaceutical composition comprising a dopamine receptor agonist selected from the group consisting of:
- D1, D2, D3, and D4 receptor agonists, such that food intake is reduced.
A method for reducing food intake comprising administering a pharmaceutical composition comprising a dopamine receptor agonist selected from the group consisting of:
- D1, D2, D3, and D4 receptor agonists, such that food intake is reduced.
Dependencies are inferred from the claim text.